Literature DB >> 14724655

Type II diabetes mellitus and impaired glucose regulation in Caucasian children and adolescents with obesity living in Germany.

M Wabitsch1, H Hauner, M Hertrampf, R Muche, B Hay, H Mayer, W Kratzer, K-M Debatin, E Heinze.   

Abstract

BACKGROUND: Recent studies reported an increased prevalence of type II diabetes mellitus in obese children and adolescents, especially in specific ethnic subgroups. The aim of this study was to determine the prevalence of type II diabetes mellitus and impaired glucose regulation in a large group of Caucasian children and adolescents with obesity living in Germany. PATIENTS AND METHODS: A total of 520 subjects (237 boys, 283 girls) (mean age: 14.0+/-2.0 y (range 8.9-20.4 y)) with a BMI>97th percentile, BMI-SDS: 2.7+/-0.5 (range 1.9-4.6), who were consecutively admitted to an in-patient obesity unit participated in the study. A 2-h oral glucose tolerance test (1.75 mg of glucose per kilogram of body weight) was performed before entering a weight-loss program and capillary blood glucose concentrations were measured. Patients were categorized into normal glucose regulation, impaired fasting glucose (IFG), impaired glucose tolerance (IGT) and diabetes. In addition, fasting venous blood was taken to determine the circulating insulin, C-peptide and lipids. Insulin resistance was estimated by homeostatic model assessment.
RESULTS: Type II diabetes was present in 1.5% (n=8) of the patients, two patients were admitted with already diagnosed type II diabetes and six patients were identified with yet unknown diabetes. IFG was detected in 3.7% (n=19) and IGT in 2.1% (n=11) of the patients. All together, in 6.7% (n=35) (95% confidence interval: 4.7-9.2%) of the patients, impaired glucose regulation (IFG, IGT) or diabetes was identified. These patients had a higher BMI-SDS, higher levels of fasting insulin and C-peptide and a higher insulin resistance index than the patients with normal glucose regulation. Risk factors for the occurrence of impaired glucose regulation were a BMI-SDS>2.5 as well as a positive parents' history for diabetes.
CONCLUSIONS: This is the first report on the prevalence of type II diabetes in a large cohort of Caucasian children and adolescents with obesity living in Europe. Impaired glucose regulation and type II diabetes were present in a substantial proportion of the patients studied. Screening for diabetes in severely obese children and adolescents (BMI-SDS>2.5) is therefore recommended. Patients identified with impaired glucose regulation need specific treatment programs in order to prevent progression to diabetes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14724655     DOI: 10.1038/sj.ijo.0802555

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  24 in total

Review 1.  Identification and treatment of metabolic complications in pediatric obesity.

Authors:  Katie Larson Ode; Brigitte I Frohnert; Brandon M Nathan
Journal:  Rev Endocr Metab Disord       Date:  2009-09       Impact factor: 6.514

2.  Pre-diabetes in Italian obese children and youngsters.

Authors:  C Brufani; D Fintini; P Ciampalini; V Nocerino; F Crea; G Giannone; P I Patera; G Valerio; M Cappa; F Barbetti
Journal:  J Endocrinol Invest       Date:  2011-06-07       Impact factor: 4.256

3.  Characterisation of morbidity in a UK, hospital based, obesity clinic.

Authors:  M A Sabin; A L Ford; J M P Holly; L P Hunt; E C Crowne; J P H Shield
Journal:  Arch Dis Child       Date:  2005-10-24       Impact factor: 3.791

4.  Risk factors for impaired glucose tolerance in obese children and adolescents.

Authors:  Michaela Kleber; Gideon de Sousa; Sophie Papcke; Thomas Reinehr
Journal:  World J Diabetes       Date:  2010-09-15

Review 5.  Clinical Pharmacokinetics and Pharmacodynamics of Antihyperglycemic Medications in Children and Adolescents with Type 2 Diabetes Mellitus.

Authors:  Fatemeh Akhlaghi; Kelly L Matson; Amir Hooshang Mohammadpour; Meghan Kelly; Asieh Karimani
Journal:  Clin Pharmacokinet       Date:  2017-06       Impact factor: 6.447

6.  Comparison of metabolic syndrome prevalence using eight different definitions: a critical approach.

Authors:  Thomas Reinehr; Gideon de Sousa; André Michael Toschke; Werner Andler
Journal:  Arch Dis Child       Date:  2007-02-14       Impact factor: 3.791

7.  [Costs involved in the early and late phases of diabetes mellitus].

Authors:  A Liebl
Journal:  Internist (Berl)       Date:  2007-07       Impact factor: 0.743

8.  Prevalence and risk factors of metabolic syndrome in obese children and adolescents: the role of the severity of obesity.

Authors:  Yasar Sen; Nurgun Kandemir; Ayfer Alikasifoglu; Nazli Gonc; Alev Ozon
Journal:  Eur J Pediatr       Date:  2008-01-17       Impact factor: 3.183

9.  Medical care of obese children and adolescents. APV: a standardised multicentre documentation derived to study initial presentation and cardiovascular risk factors in patients transferred to specialised treatment institutions.

Authors:  Thomas Reinehr; Martin Wabitsch; Werner Andler; Peter Beyer; Antje Böttner; Annette Chen-Stute; Carmen Fromme; Olaf Hampel; Klaus M Keller; Uwe Kilian; Hilde Kolbe; Thomas Lob-Corzilius; Wolfgang Marg; Hermann Mayer; Klaus Mohnike; Johannes Oepen; Clemens Povel; Brunhild Richter; Nikola Riedinger; Gerd Schauerte; Gernot Schmahlfeldt; Wolfgang Siegfried; Peer Smuda; Rainer Stachow; Andreas van Egmond-Fröhlich; Jannie Weiten; Susanna Wiegand; Sabine Witte; Volker Zindel; Reinhard W Holl
Journal:  Eur J Pediatr       Date:  2004-06       Impact factor: 3.183

Review 10.  Type 2 diabetes mellitus in children and adolescents.

Authors:  Thomas Reinehr
Journal:  World J Diabetes       Date:  2013-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.